Inhibition of restenosis formation without compromising reendothelialization as a potential solution to thrombosis following angioplasty?

Endothelium: Journal of Endothelial Cell Research

Volumn 15, Issue 1-2, 2008, Pages 85-92

  Fuchs, Alexandra Theresia ^a   Kuehnl, Andreas ^b   Pelisek, Jaroslav ^b   Rolland, Pierre Henri ^c   Mekkaoui, Choukri ^c   Netz, Heinrich ^a   Nikol, Sigrid ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

C Type Natriuretic Peptide; Neointima Formation; Nonviral Gene Transfer; Reendothelialization; Subacute Thrombosis

Indexed keywords

BETA GALACTOSIDASE; DNA; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C;

ANGIOGRAPHY; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSFECTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTIMA; MORPHOMETRICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMID; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER; SWINE; THROMBOSIS;

ANGIOGRAPHY; ANGIOPLASTY, BALLOON; ANIMALS; ARTERIES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COLORING AGENTS; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DNA; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EVANS BLUE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; IMMUNOHISTOCHEMISTRY; MUSCLE, SMOOTH, VASCULAR; NATRIURETIC PEPTIDE, C-TYPE; SWINE; THROMBOSIS; TIME FACTORS; TRANSFECTION; TUNICA INTIMA;

SUS;

EID: 46049112245     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/10623320802092484     Document Type: Article

References (40)

1. Armeanu, S., Pelisek, J., Krausz, E., Fuchs, A., Groth, D., Curth, R., Keil, O., Quilici, J., Rolland, P. H., Reszka, R. and Nikol, S. (2000) Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo. Molecular Therapy, 1, pp. 366-375.
2. Asahara, T., Chen, D., Tsurumi, Y., Kearney, M., Rossow, S., Passeri, J., Symes, J. F. and Isner, J. M. (1996) Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. Circulation, 94, pp. 3291-3302.
3. Barr, C. S., Rhodes, P. and Struthers, A. D. (1996) C-type natriuretic peptide. Peptides, 17, pp. 1243-1251.
4. Deiner, C., Schwimmbeck, P. L., Koehler, I. S., Loddenkemper, C., Noutsias, M., Nikol, S., Schultheiss, H. P., Yla-Herttuala, S. and Pels, K. (2006) Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries. Atherosclerosis, 189, pp. 123-132.
5. Engelmann, M. G., Shimizu, M., Pelisek, J., Fuchs, A., Golda, A., Mekkaoui, C., Fraunberger, P., Rolland, P. H. and Nikol, S. (2004) Comparison of surgical versus endovascular occlusion models in pig femoral arteries. Journal of Endovascular Therapy, 11, pp. 71-79.
6. Erbel, R., Haude, M., Hopp, H. W., Franzen, D., Rupprecht, H. J., Heublein, B., Fischer, K., de Jaegere, P., Serruys, P., Rutsch, W. and Probst, P. (1998) Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group. New England Journal of Medicine, 339, pp. 1672-1678.
7. Garg, U. C. and Hassid, A. (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. Journal of Clinical Investigation, 83, pp. 1774-1777.
8. Hedman, M., Hartikainen, J., Syvanne, M., Stjernvall, J., Hedman, A., Kivela, A., Vanninen, E., Mussalo, H., Kauppila, E., Simula, S., Narvanen, O., Rantala, A., Peuhkurinen, K., Nieminen, M. S., Laakso, M. and Yla-Herttuala, S. (2003) Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: Phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation, 107, pp. 2677-2683.
9. Huehns, T. Y., Krausz, E., Mrochen, S., Schmid, M., Engelmann, M. G., Esin, S., Schrittenloher, P. K., Hofling, B., Gunzburg, W. H. and Nikol, S. (1999) Neointimal growth can be influenced by local adventitial gene manipulation via a needle injection catheter. Atherosclerosis, 144, pp. 135-150.
10. Korovesis, S., Karvouni, E., Giazitzoglou, E. and Katritsis, D. (2005) Drug-eluting stents: Immediate and long-term results. Hellenic Journal of Cardiology, 46, pp. 330-335.
11. Lemos, P. A., Saia, F., Ligthart, J. M., Arampatzis, C. A., Sianos, G., Tanabe, K., Hoye, A., Degertekin, M., Daemen, J., McFadden, E., Hofma, S., Smits, P. C., De Feyter, P., Van Der Giessen, W. J., Van Domburg, R. T. and Serruys, P. W. (2003) Coronary restenosis after sirolimus-eluting stent implantation: Morphological description and mechanistic analysis from a consecutive series of cases. Circulation, 108, pp. 257-260.
12. Lemos, P. A., Serruys, P. W., Van Domburg, R. T., Saia, F., Arampatzis, C. A., Hoye, A., Degertekin, M., Tanabe, K., Daemen, J., Liu, T. K., McFadden, E., Sianos, G., Hofma, S. H., Smits, P. C., Van Der Giessen, W. J. and De Feyter, P. J. (2004) Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation, 109, pp. 190-195.
13. Levin, E. R., Gardner, D. G. and Samson, W. K. (1998) Natriuretic peptides. New England Journal of Medicine, 339, pp. 321-328.
14. Liistro, F. and Colombo, A. (2001) Late acute thrombosis after paclitaxel eluting stent implantation. Heart, 86, pp. 262-264.
15. Liistro, F., Fineschi, M., Angioli, P., Sinicropi, G., Falsini, G., Gori, T., Ducci, K., Bravi, A. and Bolognese, L. (2006) Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: The TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry. Journal of the American College of Cardiology, 48, pp. 270-275.
16. Morice, M. C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban, H. E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., Molnar, F. and Falotico, R. (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New England Journal of Medicine, 346, pp. 1773-1780.
17. Morishige, K., Shimokawa, H., Yamawaki, T., Miyata, K., Eto, Y., Kandabashi, T., Yogo, K., Higo, T., Egashira, K., Ueno, H. and Takeshita, A. (2000) Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. Journal of the American College of Cardiology, 35, pp. 1040-1047.
18. Morishita, R., Gibbons, G. H., Ellison, K. E., Nakajima, M., von der, L. H., Zhang, L., Kaneda, Y., Ogihara, T. and Dzau, V. J. (1994) Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. Journal of Clinical Investigation, 93, pp. 1458-1464.
19. Naruko, T., Ueda, M., van der Wal, A. C., van der Loos, C. M., Itoh, H., Nakao, K. and Becker, A. E. (1996) C-type natriuretic peptide in human coronary atherosclerotic lesions. Circulation, 94, pp. 3103-3108.
20. Neumann, F. J., Desmet, W., Grube, E., Brachmann, J., Presbitero, P., Rubartelli, P., Mugge, A., Di Pede, F., Fullgraf, D., Aengevaeren, W., Spedicato, L. and Popma, J. J. (2005) Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation, 111, pp. 2107-2111.
21. Nikol, S., Huehns, T. Y., Krausz, E., Armeanu, S., Engelmann, M. G., Winder, D., Salmons, B. and Hoefling, B. (1999) Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation. Gene Therapy, 6, pp. 737-748.
22. Nikol, S., Pelisek, J., Engelmann, M. G., Shimizu, M., Fuchs, A., Golda, A., Armeanu, S., Mekkaoui, C. and Rolland, P. H. (2002) Vascular endothelial growth factor (VEGF165) and its influence on angiogenesis versus arteriogenesis in different vascular beds. Journal of Endovascular Therapy, 9, pp. 842-854.
23. Ohno, N., Itoh, H., Ikeda, T., Ueyama, K., Yamahara, K., Doi, K., Yamashita, J., Inoue, M., Masatsugu, K., Sawada, N., Fukunaga, Y., Sakaguchi, S., Sone, M., Yurugi, T., Kook, H., Komeda, M. and Nakao, K. (2002) Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide. Circulation, 105, pp. 1623-1626.
24. Ong, A. T., McFadden, E. P., Regar, E., de Jaegere, P. P., Van Domburg, R. T. and Serruys, P. W. (2005) Late angiographic stent thrombosis (LAST) events with drug-eluting stents. Journal of the American College of Cardiology, 45, pp. 2088-2209.
25. Park, S. J., Shim, W. H., Ho, D. S., Raizner, A. E., Park, S. W., Hong, M. K., Lee, C. W., Choi, D., Jang, Y., Lam, R., Weissman, N. J. and Mintz, G. S. (2003) A paclitaxel-eluting stent for the prevention of coronary restenosis. New England Journal of Medicine, 348, pp. 1537-1545.
26. Pelisek, J., Armeanu, S. and Nikol, S. (2001) Quiescence, cell viability, apoptosis and necrosis of smooth muscle cells using different growth inhibitors. Cell Proliferation, 34, pp. 305-320.
27. Pelisek, J., Engelmann, M. G., Golda, A., Fuchs, A., Armeanu, S., Shimizu, M., Mekkaoui, C., Rolland, P. H. and Nikol, S. (2002) Optimization of nonviral transfection: Variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model. Journal of Molecular Medicine, 80, pp. 724-736.
28. Pelisek, J., Kuehnl, A., Rolland, P. H., Mekkaoui, C., Fuchs, A., Walker, G. F., Ogris, M., Wagner, E. and Nikol, S. (2004) Functional analysis of genomic DNA, cDNA, and nucleotide sequence of the mature C-type natriuretic peptide gene in vascular cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, pp. 1646-1651.
29. Popma, J. J. and Ellis, S. G. (1990) Intracoronary stents: Clinical and angiographic results. Herz, 15, pp. 307-318.
30. Savage, M. P., Fischman, D. L., Schatz, R. A., Teirstein, P. S., Leon, M. B., Baim, D., Ellis, S. G., Topol, E. J., Hirshfeld, J. W. and Cleman, M. W. (1994) Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. Palmaz-Schatz Stent Study Group. Journal of the American College of Cardiology, 24, pp. 1207-1212.
31. Scheller, B., Hehrlein, C., Bocksch, W., Rutsch, W., Haghi, D., Dietz, U., Bohm, M. and Speck, U. (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. New England Journal of Medicine, 355, pp. 2113-2124.
32. Scheller, B., Speck, U., Abramjuk, C., Bernhardt, U., Bohm, M. and Nickenig, G. (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation, 110, pp. 810-814.
33. Shuchman, M. (2006) Trading restenosis for thrombosis? New questions about drug-eluting stents. New England Journal of Medicine, 355, pp. 1949-1952.
34. Stone, G. W., Ellis, S. G., Cannon, L., Mann, J. T., Greenberg, J. D., Spriggs, D., O'Shaughnessy, C. D., DeMaio, S., Hall, P., Popma, J. J., Koglin, J. and Russell, M. E. (2005) Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. Journal of the American Medical Association, 294, pp. 1215-1223.
35. Suzuki, T., Yamazaki, T. and Yazaki, Y. (2001) The role of the natriuretic peptides in the cardiovascular system. Cardiovascular Research, 51, pp. 489-494.
36. Van Der Giessen, W. J., Lincoff, A. M., Schwartz, R. S., van Beusekom, H. M., Serruys, P. W., Holmes Jr., D. R., Ellis, S. G. and Topol, E. J. (1996) Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation, 94, pp. 1690-1697.
37. Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T., Mihalcsik, L., Tespili, M., Valsecchi, O. and Kolodgie, F. D. (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?. Circulation, 109, pp. 701-705.
38. Virmani, R., Liistro, F., Stankovic, G., Di Mario, C., Montorfano, M., Farb, A., Kolodgie, F. D. and Colombo, A. (2002) Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation, 106, pp. 2649-2651.
39. Walter, D. H., Cejna, M., Diaz-Sandoval, L., Willis, S., Kirkwood, L., Stratford, P. W., Tietz, A. B., Kirchmair, R., Silver, M., Curry, C., Wecker, A., Yoon, Y. S., Heidenreich, R., Hanley, A., Kearney, M., Tio, F. O., Kuenzler, P., Isner, J. M. and Losordo, D. W. (2004) Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: An alternative strategy for inhibition of restenosis. Circulation, 110, pp. 36-45.
40. Yla-Herttuala, S. (2006) An update on angiogenic gene therapy: Vascular endothelial growth factor and other directions. Current Opinions in Molecular Therapy, 8, pp. 295-300.